Article Details
Retrieved on: 2024-10-16 17:46:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology ... immune system's cancer-fighting capabilities. By targeting cancer ...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here